Asian Multinational Retrospective Analysis for Infectious Complications in Patients Treated With Alemtuzumab.

Trial Profile

Asian Multinational Retrospective Analysis for Infectious Complications in Patients Treated With Alemtuzumab.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2012

At a glance

  • Drugs Alemtuzumab (Primary)
  • Indications Acute myeloid leukaemia; Aplastic anaemia; Haematological malignancies; Non-Hodgkin's lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 22 May 2012 Actual patient number (182) and lead trial investigators added as reported by ClinicalTrials.gov.
    • 22 May 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
    • 22 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top